India's second wave may impede economic recovery, says S&P : Bulletin: Business Today
Business Today
Loading...
 

India's second wave may impede economic recovery, says S&P

Loading the player...

Rashi Bisaria | April 29, 2021

India's second COVID-19 wave may impede economic recovery, says S&P

Credit rating agency S&P Global said on Wednesday the second wave of COVID-19 infections in India could impede the country's economic recovery and expose other nations to further waves of outbreaks. India's healthcare system has been overwhelmed, with the world's second most populous country reporting more than 300,000 new COVID-19 cases daily over the past six days.

COVID-19 second wave can delay Air India divestment: DIPAM Secretary

The second wave of COVID-19 pandemic in the country can delay government's disinvestment plan for national carrier Air India, Department of Investment and Public Asset Management (DIPAM) Secretary Tuhin Kanta Pandey said on Wednesday. The government is selling its entire 100 per cent stake in Air India, which has been in losses ever since its merger with domestic operator Indian Airlines in 2007. It was targeting to complete disinvestment of the airline by September this year.

COVID-19: Reliance Industries to set up 1,000-bed hospital in Jamnagar

Reliance Industries Ltd (RIL) will set up a 1,000-bed COVID-19 hospital in Jamnagar with oxygen supply amidst a surge in coronavirus cases in the country, including Gujarat. Gujarat Chief Minister Vijay Rupani spoke with RIL CMD Mukesh Ambani and sought his help in augmenting COVID-19 bed capacity.

COVID-19 vaccination: Over 80 lakh registrations on CoWin portal in 3 hours

Within three hours of commencement of registration for 18-44 years age group, more than 80 lakh people registered themeselves on the CoWin portal for COVID-19 vaccination. The system is recording 55,000 hits per second and is completely stable, the government said, adding that more than 1.45 crore SMS were delivered successfully.

Serum Institute reduces Covishield price for govt hospitals to Rs 300

Serum Institute of India has decided to reduce the price of its coronavirus vaccine Covishield to Rs 300 from the earlier rate of Rs 400. The decision was announced by CEO Adar Poonawalla, who said that this reduction of price is a philanthropic gesture on the part of Serum. He added that this price cut will save thousands of crores of state funds as well as save countless lives.

Jio Platforms, Byju's make it to TIME Magazine's first-ever list of 100 most influential firms

Two Indian firms, Reliance Industries' technology arm Jio Platforms and e-learning startup Byju's have figured in the TIME Magazine's first-ever list of 100 most influential companies. On its website, Time said companies shaping the future are at the heart of the first ever TIME 100 Most Influential Companies.

More from this section